GlassScriptPhysician profile
Mary T Riggs
NPI 1285799627
$830.99
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $132 · 2021: $16.63.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $234.49 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $124.45 | 2019 | |
| Therapeuticsmd, INC. | $100.62 | 2019-2020 | |
| Avion Pharmaceuticals | $73.94 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.25 | 2019 | |
| Abbvie INC. | $44.92 | 2019 | |
| Allergan, INC. | $44.62 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $35.70 | 2019 | |
| Glaxosmithkline, LLC. | $30.11 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.92 | 2019 | |
| Astellas Pharma US INC | $17.66 | 2020 | |
| Hologic Sales and Service, LLC | $16.63 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.78 | 2020 | |
| Horizon Therapeutics Plc | $12.19 | 2020 | |
| Boston Scientific Corporation | $11.71 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Riggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.